This piece was originally published in the April 2022 issue of Policy & Practice magazine.
Health inequity remains a significant problem in the United States. While COVID-19 did not create the inequity, the pandemic dramatically exposed and compounded the disparities. Addressing the needs of populations historically disinvested is the prerequisite for a fair and thriving society. There is growing recognition that the status quo is unacceptable and increasingly urgent calls for change at the federal and state levels.
The root causes of health inequity are challenging to address. In addition to being couched in neutral language or binary terms of “right vs. wrong” or “good vs. bad,” the root causes are laden with hidden judgments against people who are already disadvantaged. Simply because a policy or process exists does not mean that it is right or just.
Consider a common managed care process: prior authorization. When a patient needs specialized services, their doctor may need to confirm that the health plan is willing to pay for these services. If the insurance company rejects the request, the patient has the right to appeal that decision with the support of the physician. When a person with Medicaid appeals a decision, they may also have the option to request Continuation of Benefits. Checking that box on the paperwork helps ensure that their services continue while the health plan reviews the appeal.
But amid complex legal language and explanations for the denial, patients may not recognize their right to continued care. Some may not even understand what “Continuation of Benefits” means.
This is one of many examples where equity-focused analytics can help. To explore the question — Is this policy further marginalizing certain populations? — equity-focused analytics would pull data to measure differences in appeal decision times when Continuation of Benefits is selected. This exercise also would help identify whether certain groups or demographics are less likely to select Continuation of Benefits and therefore less likely to have equitable access to care.
If there are differences, what might account for them? When we examine patients who do not select Continuation of Benefits, is there a correlation based on their primary language? Are there differences based on patients’ disability groups, race/ethnicity or age? If the answer to any of those questions is “yes,” there is a strong case that this policy is imposing barriers to continuous care and needs to be changed or removed.